Dealings involving intentional release

Details on the applications and licences for Dealings involving an intentional release (DIR) of a GMO into the environment.

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

Filter results

You can narrow down the results using the filters

Dealings involving an Intentional Release (DIR) of GMOs into the environment are dealings with GMOs which can take place outside of containment facilities.

8 results
Licence number Project title Organisation Category Release Issue date Licence status

Commercial supply of a genetically modified COVID-19 vaccine

Janssen-Cilag Pty Ltd

Medical Commercial Current

Commercial supply of a genetically modified COVID-19 vaccine

AstraZeneca Pty Ltd

Medical Commercial Current

Commercial supply of a genetically modified cholera vaccine, Vaxchora®

Biocelect Pty Ltd

Medical Commercial Current

Commercial supply of Dengvaxia, an attenuated GM dengue vaccine

Sanofi-Aventis Australia Pty Ltd

Medical Commercial Current

Commercial supply of attenuated GM influenza vaccines

AstraZeneca Pty Ltd

Medical Commercial Current

Commercial supply of a tumour-selective genetically modified virus for cancer therapy

Amgen Australia Pty Ltd

Medical Commercial Current

Commercial release of a genetically modified live viral vaccine to protect against Japanese encephalitis (IMOJEV)

Sanofi-Aventis Australia Pty Ltd

Medical Commercial Current

Commercial release of recombinant live oral cholera vaccine (Orochol® vaccine)

CSL Ltd

Medical Commercial Surrendered